Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Piper Sandler Maintains Neutral on Comerica, Raises Price Target to $54

Author: Benzinga Newsdesk | April 19, 2024 01:54pm
Piper Sandler analyst Scott Siefers maintains Comerica (NYSE:CMA) with a Neutral and raises the price target from $53 to $54.

Posted In: CMA

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist